On February 5, 2009, OCRF, in partnership with the Gynecologic Cancer Foundation (GCF), announced that Barbara Goff, M.D., Director of Gynecologic Oncology at the University of Washington, has been named to lead the OCRF Ovarian Cancer Symptoms Study. The award was presented by OCRF Scientific Advisory Board Vice-Chair, Carmel Cohen, M.D., at the Society of Gynecologic Oncologists 40th Annual Meeting on Women’s Cancer™ in San Antonio, Texas.
The study builds on an original symptoms study conducted by Dr. Goff which formed the basis for the first national Consensus Statement on Ovarian Cancer Symptoms, issued in 2007. Click here to read the New York Times article about Dr. Goff’s prior work.
The grant will allow researchers to forge ahead in their efforts to develop a systematic symptoms screening process for ovarian cancer—a critical step, because ovarian cancer is much easier to cure when caught early. “Through the continuation of this vital research, we aim to debunk the myth that ovarian cancer is a ‘silent disease,’ and empower both physicians and women to be better equipped to recognize symptoms in their earliest stage,” Dr. Goff said. “Huge progress has been made, and now it’s time to take the next step.”
